PRPO, US74019L6020

Precipio reports USD 7.02 million Q2 revenue growth for stock investors

Published on 10/16/2026 at 00:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revenue reached USD 7.02 million in Q2 2026, up 24.18 percent year over year. Precipio stock centers on the November 16 report.

Revenue growth and reporting date

  • Second-quarter 2026 revenue reached USD 7.02 million, up 24.18 percent year over year.
  • Second-quarter 2026 diluted earnings per share were a loss of USD 0.12.
  • Precipio's next earnings report is scheduled for November 16, 2026.
PRPO, US74019L6020, Illustration mit AI erstellt.

Precipio (ISIN US74019L6020) generated USD 7.02 million in second-quarter 2026 revenue, up 24.18 percent from USD 5.65 million a year earlier. ScanX News reported the figures on September 18, 2026, while diluted earnings per share were a loss of USD 0.12.

What does Q2 mean for margins?

The revenue comparison is the strongest part of the report, but the earnings figure shows that growth did not yet produce a quarterly profit. Precipio's second-quarter 2026 loss per share contrasted with earnings per share of USD 0.05 in the year-earlier quarter, according to ScanX News.

The company operates cancer diagnostic services and products aimed at reducing laboratory misdiagnosis. Its investor-relations page describes collaborations with academic institutions and a platform for delivering diagnostic information to physicians and patients. Precipio also identifies clinical services, products and quarterly business updates as investor resources.

Three dated stock developments

On August 14, 2026, Precipio filed its second-quarter report, according to Business Quant. On September 18, 2026, the results coverage highlighted USD 7.02 million in revenue and the USD 0.12 per-share loss. On October 15, 2026, the Nasdaq last price was USD 22.54 at 4:00 p.m. ET.

When is the next report?

The next earnings report is scheduled for November 16, 2026, according to TradingView. That date gives investors a defined checkpoint for judging whether revenue growth can translate into sustained profitability.

Market value and operating scale

Precipio had a market capitalization of USD 40.4 million on October 15, 2026. Its 52-week range was USD 16.40 to USD 33.63, placing the latest Nasdaq price below the yearly high while remaining above the low. The company reported USD 3.08 million in cash at June 30, 2026, alongside second-quarter operating cash flow of USD 660,000.

Precipio stock was last at USD 22.54 on Nasdaq on October 15, 2026 at 4:00 p.m. ET.

Precipio stock facts

  • Company: Precipio, Inc.
  • ISIN: US74019L6020
  • Ticker: PRPO
  • Primary exchange: Nasdaq
  • Market capitalization: USD 40.4 million (as of October 15, 2026)
  • 52-week range: USD 16.40-33.63 (as of October 15, 2026)
  • Sector / Industry: Health care / cancer diagnostics
  • Next earnings date: November 16, 2026

Market context: Market report Nasdaq Composite.

More news and analyses on Precipio stock

Disclaimer...
en | US74019L6020 | PRPO | boerse | 70334069 | bgmi